Literature DB >> 7814462

Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members.

R Maran1, M Dueymes, Y Adler, Y Shoenfeld, P Youinou.   

Abstract

IgG subclasses of anti-pyruvate dehydrogenase (PDH) antibodies were determined in 72 patients with primary biliary cirrhosis. All isotypes were detected, but IgG3, IgG1, and IgG2 predominated independently or in association. An average of 33.3 +/- 19.1% of the anti-PDH IgG was IgG1 (mean optical density, 0.863 +/- 0.783, vs 0.053 +/- 0.038 in the normal controls), 25.0 +/- 17.8 IgG2 (0.652 +/- 0.656 vs 0.062 +/- 0.030), 39.5 +/- 23.4% IgG3 (1.140 +/- 0.917 vs 0.010 +/- 0.023), and 2.4 +/- 7.4% IgG4 (0.060 +/- 0.182 vs 0.012 +/- 0.007). Anti-PDH IgG were restricted to IgG1 in the family members of patients (0.180 +/- 0.403).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814462     DOI: 10.1007/bf01540986

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.

Authors:  N Tuaillon; C Andre; J P Briand; E Penner; S Muller
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

3.  Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method.

Authors:  C J Stanley; R N Perham
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

4.  Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.

Authors:  U Sundin
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis.

Authors:  C Vincent; G Serre; J P Basile; H C Lestra; E Girbal; M Sebbag; J P Soleilhavoup
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 6.  The forces driving autoimmune disease.

Authors:  I M Roitt; P R Hutchings; K I Dawe; N Sumar; K B Bodman; A Cooke
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

7.  A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.

Authors:  F C Nielsen; A Rødgaard; R Djurup; F Somnier; S Gammeltoft
Journal:  J Immunol Methods       Date:  1985-11-07       Impact factor: 2.303

8.  Relationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus.

Authors:  M Dueymes; J Barrier; J F Besancenot; J Clèdes; C Conri; G Dien; A A Drosos; J M Dueymes; P Galanaud; B Grobois
Journal:  Int Arch Allergy Immunol       Date:  1993       Impact factor: 2.749

9.  NIH conference: Primary biliary cirrhosis: a model autoimmune disease.

Authors:  S P James; J H Hoofnagle; W Strober; E A Jones
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

10.  Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting.

Authors:  N Zurgil; F Konikoff; R Bakimer; H Slor; Y Shoenfeld
Journal:  Autoimmunity       Date:  1989       Impact factor: 2.815

View more
  2 in total

Review 1.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 2.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.